Embryonal Rhabdomyosarcoma: Who Gets Germline Testing?
Carousel1 min read·Published Nov 2026

Embryonal Rhabdomyosarcoma: Who Gets Germline Testing?

Clinical case of pediatric rhabdomyosarcoma with CT image showing chest wall mass and germline testing question.
Blue slide showing answer C: every newly diagnosed solid tumor patient should receive genetic counseling.
Slide explaining TP53 Li-Fraumeni syndrome and germline testing protocols for pediatric solid tumors.
Blue slide explaining why solid tumor programs test all patients for germline mutations to reduce leukemia risk.
Final slide inviting viewers to follow for more pediatric surgery education content on oncology.
1 / 6

Carousel · Nov 2026 · 1 min read

In brief

In brief

Educational carousel covering sarcoma diagnosis and management, likely part of a clinical teaching series on pediatric solid tumors including soft tissue and bone sarcomas.

Written by the GCMD Library team from the carousel.

Slides

6 pages · click to turn to one
Oncology — sarcoma. A social-media carousel made possible by Cincinnati Children's.
The text on each slide
  1. Oncology | Clinical Foundations | Made possible by Cincinnati Children's | A 2yo with cough and increased work of breathing. CT shows a 10 cm chest wall mass, ribs displaced rather than destroyed. Biopsy: embryonal rhabdomyosarcoma. | WHO GETS GERMLINE TESTING? | A.) Those with a family history of cancer | B.) Those with syndromic features on exam | C.) Every newly diagnosed solid tumor patient | 1/6
  2. Oncology | Clinical Foundations | Made possible by Cincinnati Children's | THE ANSWER | c.) EVERY NEWLY DIAGNOSED SOLID TUMOR PATIENT | 15% of sarcoma patients may carry a significant hereditary predisposition | 2/6
  3. Oncology | Clinical Foundations | Made possible by Cincinnati Children's | WHAT CAME BACK | TP53 LI-FRAUMENI SYNDROME | An inherited predisposition that raises the risk of multiple cancers, sarcomas among them. | Dr. Pressey's team tests every new solid tumor patient. Rhabdomyosarcoma at this age is an indication for germline testing on its own. | Joseph G. Pressey, MD | Director, Solid Tumor and Sarcoma Programs, Co-Director, Young Adult Oncology Program, Cincinnati Children's | 3/6
  4. Oncology | Clinical Foundations | Made possible by Cincinnati Children's | HOW DOES THIS DIAGNOSIS AFFECT TREATMENT CHOICE? | For rhabdomyosarcoma, we would | Joseph G. Pressey, MD | Director, Solid Tumor and Sarcoma Programs, Co-Director, Young Adult Oncology Program, Cincinnati Children's | 4/6
  5. Oncology | Clinical Foundations | Made possible by Cincinnati Children's | THE TAKEAWAY | WHY THE SOLID TUMOR PROGRAM TESTS EVERYONE | A germline result can change the regimen. | The change is treatment lowers the risk of a treatment related leukemia. | 5/6
  6. Oncology | Clinical Foundations | Made possible by Cincinnati Children's | FOLLOW FOR MORE PEDIATRIC SURGERY EDUCATION. | 6/6
Intelligent Search· scoped to this carousel · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.